Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain

被引：0

作者：

Terrés, CR

Rodríguez, J

Bolinder, B

de Pablos, P

机构：

[1] HERO Consulting Hlth Econ & Res Outcomes, Madrid, Spain

[2] Aventis Pharma, Bridgewater, NJ USA

[3] Univ Las Palmas de Gran Canaria, Las Palmas Gran Canaria, Spain

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

961

引用

页码：A345 / A345

页数：1

共 50 条

[21] Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain
Delgado, E.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 281 - 288
[22] Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETES, 2001, 50 : A112 - A112
[23] Safety and efficacy of insulin glargine compared with NPH insulin in older adults with type 2 diabetes mellitus
Lee, P. G.
Chang, A. M.
Blaum, C.
Vlajnic, A.
Miller, M. F.
Halter, J. B.
[J]. DIABETOLOGIA, 2009, 52 : S382 - S382
[24] A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus
Rostami, Parastoo
Setoodeh, Aria
Rabbani, Ali
Nakhaei-Moghadam, Maryam
Najmi-Varzaneh, Farnaz
Rezaei, Nima
[J]. IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (02) : 173 - 178
[25] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
Nechevska, L.
Nechevski, M.
Nechevska, E.
Boskovski, B.
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[26] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
Heise, T
Nosek, L
Draeger, E
Ronn, BB
Kapitza, C
Heinemann, L
[J]. DIABETOLOGIA, 2003, 46 : A6 - A7
[27] Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies
Duckworth, William
Davis, Stephen N.
[J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 196 - 204
[28] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
Dailey, G. E.
Gao, L.
Aurand, L.
Garg, S. K.
[J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
[29] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S7 - S19
[30] Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus
Gupta, K. S.
Gupta, U.
[J]. VALUE IN HEALTH, 2007, 10 (03) : A70 - A70

← 1 2 3 4 5 →